text:
Rizzo powers Cubs past Reds in series finale
Hits two-run homer, scores three runs as Jackson picks up victory
CINCINNATI -- The Cubs starting rotation performed well in April. The bullpen had its early struggles, but has come on nicely of late. The offense? Well, that's been an issue all month, and the main reason why the Cubs are lagging in the standings.
Hitting wasn't so much of an issue, however, on Wednesday night at Great American Ball Park. The Cubs scored early and often off Tony Cingrani and piled on more at the end againnst the Reds' bullpen, leaving town with a convincing 9-4 win and managing a split of the rain-shortened two-game set.
"We've been having a tough time trying to tack on runs and scoring runs in bunches," manager Rick Renteria said. "Today was an example of what a club can do."
The Cubs finished April with a 9-17 record and no series wins, but ended the month on a high note after Cubs' hitters set the tone early against Cingrani.
Emilio Bonifacio led off with a single and scored on Anthony Rizzo's two-run homer. The Cubs added another run in the third on an RBI single by Starlin Castro, who logged two hits on the night and raised his batting average to .308.
The Cubs added four runs in the ninth, including a two-run single by Nate Schierholtz and an RBI double by Bonifacio, making this the closest thing to a blowout that the Cubs have had in a while.
If the Cubs could generate this kind of offense with more regularity, they'd probably be able to move up a few notches in the National League Central standings. Lately, the talk around this team has focused on a need to make sure all facets of the game are coming together at one time. The starters and relievers have more than held up their end. The defense has come around, too.
And on Wednesday, the Cubs got a true glimpse of how much good can happen when the bats come to life.
"This team still has a lot of upside," Rizzo said. "We've shown glimpses of it. A glimpse tonight with our bullpen coming in and locking the game down. It's pretty impressive. If we score runs -- and guys are swinging the bat well -- I think we're going to start winning some ballgames and get back in it."
Say this for the Cubs -- they've been consistent. Their April performance looks pretty close to their first month of the season last year. They had a 3.78 ERA through April in 2013, as compared to a 3.79 this time around. Last year Cubs hitters were batting .235 as April drew to a close. In 2014: .236.
Yet there seems to be more optimism surrounding this bunch than there was a year ago. That's probably due in part to what the bullpen has managed to do in the last couple of weeks, stifling hitters once the game gets to the late innings.
Cubs relievers have combined for 14 scoreless frames in the team's last six games. That includes efforts from left-hander Wesley Wright, who retired Billy Hamilton and Joey Votto in the seventh to stretch his scoreless streak to seven games.
Neil Ramirez and Hector Rondon took care of the final two frames, recording a combined three strikeouts.
"We've got really exciting arms," Renteria said. "They did a nice job."
Starting righty Edwin Jackson had similar praise for a 'pen that made sure no more damage was done after the Reds tagged him for four runs.
"You have confidence in those guys that when you come out of a game they're going to continue to pick up the slack," Jackson said. "Whether there's men on base or if there's nobody on base. The pitching staff as a whole has been pretty good this year. We just have to continue to feed off of each other and have belief in ourselves that we can go out there and get outs."
Usually when a team is getting good pitching but still struggling for wins, there's less reason to panic. That appears to be the case with the Cubs, who sound confident despite their poor record.
"It's definitely going to create a buzz in the division and around the league that the Cubs have those power arms," Rizzo said. "We just have to score runs and let our pitching do the rest."
Alyson Footer is a national correspondent for MLB.com. Follow her on Twitter @alysonfooter. This story was not subject to the approval of Major League Baseball or its clubs.


text:
Cueto to begin rehab assignment soon
ST. LOUIS -- Plans are not yet written in cement, but all indications are that Johnny Cueto will soon begin a Minor League rehab assignment.
"We just want to make sure everybody is on board with it," pitching coach Bryan Price said on Tuesday.
Cueto, who is on the 15-day disabled list with a strained right lat, reported no issues a day after a 45-pitch bullpen session on Monday.
"He's fine. He came in and got treatment. He's strong," Price said. "Now it's just a matter of verifying that he's OK as opposed to just firing him off into a game, and there's still a twinge and you have to DL him again. There's a strong possibility that he'll make an outing or two in our player-development system to verify he's OK."
Because Cueto is very competitive and likes to push himself, the Reds will be deliberate in building his pitch count and making sure he doesn't try to rush back too soon. He is already eligible for activation at any time.
"We've got to do what we think is best for him," manager Dusty Baker said. "We also want to keep him on the field so he doesn't go back down again."
Mark Sheldon is a reporter for MLB.com. Read his blog, Mark My Word, and follow him on Twitter @m_sheldon. This story was not subject to the approval of Major League Baseball or its clubs.

subset: commoncrawl


text:
The Ohio Machine will be participating in " Boo at the Zoo " with Columbus Zoo & Aquarium from October 26-28. Come stop by our candy station and you could win cool Ohio Machine prizes!!
Friday, Oct. 26 - 5 pm - 9 pm
Saturday, Oct. 27: 10 am - 9 pm
Sunday, Oct. 28: 10 am - 8 pm
The weekend will feature candy stations, magicians, a haunted train ride, special themed regions of the Zoo and other thrilling Halloween activities. In addition, the Zoo will have Batman, Robin, Wonder Woman, the Green Lantern and the Joker on hand to help celebrate Halloween. These amazing super heroes will be performing shows and appearing in the Zoo's Character Caravans.
Guests that enjoy shows also won't want to miss the popular Animals on Safari show that features dogs and cats that were rescued from local shelters. Also, those interested in catching a Halloween themed program won't want to miss "Creature Features" at the Animal Encounters Village.
The Zoo's animals will also get into the Halloween spirit, with pumpkin smashes on Saturday of Boo at the Zoo. This delightfully haunting fun event will offer a Halloween experience in an atmosphere that only the Zoo can provide!
Boo at the Zoo is included in the price of admission and free to Columbus Zoo members. Children are welcome to dress in costume however; only adults accompanied by a child or children under 13-years-old will be permitted to wear costumes on Zoo grounds.
General admission is $12.99 for adults, $7.99 for children ages 2 to 9 and seniors 60+. Children under 2 and Columbus Zoo members are free.
Click here for more information on "Boo at the Zoo."


text:
Sign Up
Manicures come and go, but they don't have to have such a short lifespan. If you're tired of shelling out money for a nail makeover only to have it chip after the first few days of wear, then there are a few tricks for you to try.
First of all, it's important to understand that your nails, which primarily act as armor for the softer part of your fingers, are made of a different compound than your skin. This layer of proteins, called keratin, is very porous, allowing the skin beneath it to breathe easily. When that porous surface isn't as clean as we think they are, no amount of base coat or top coat will help that nail polish stay in place. Scrub your nails thoroughly before any kind of manicure happens!
Also, strive to use healthy products that nourish and condition this part of your body. Nails may feel strong, but if you add the wrong chemicals, the keratin can break down. Weaknesses here can let in bacteria. Try using the CND SolarSpeed Spray. Not only will it help along the drying process, but it will also condition your nails as it works.
Recommended Products
Related posts


text:
Worth discussion, in my opinion, is trading JO to the Nets for Kidd and something else.
Or, JO and Tins for Kidd and Jefferson. Does that work?
I'm sure many will respond with screams not to trade JO, but it needs to be discussed with an open mind. His value is extremely high right now (it wasn't a year ago, if you remember.) He could opt out of his contract this summer. And we are stacked with power forwards right now, one of them (Diogu) with the potential to be as good as JO in a couple of years.
Is there anything we could take away from New Jersey that would make you guys entertain a trade that has JO for Kidd at the core?


text:
This is a very interesting award winning documentary from the BBC about the influence of Freud's and Willhelm Reich's ideas over modern society.
It is all the more interesting for buddhists, as it has a lot to do with how cultures around the world have evolved to celebrate and cater to self-indulgence, which is in direct opposition with the teachings of the Buddha. It allows to understand better our relations to desire and consumerism as well as the modern structures of our societies.


text:
Welcome to the world of Gliss!
Gliss is the hair repair expert and your reliable partner for solving all kinds of hair issues! Please choose your country to be forwarded to your local website. There, you will find various information about the brand Gliss, its highly efficient Liquid Hair Repair Technology and the products that suit your individual hair type and needs.
Experience beautiful, repaired hair – with Gliss!


text:
Comparison of Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
|Pneumonia, Pneumocystis Carinii HIV Infections
|Drug: Trimetrexate glucuronate Drug: Pentamidine isethionate Drug: Sulfamethoxazole-Trimethoprim Drug: Leucovorin calcium
|Phase 3
|Study Type:
|Study Design:
|Intervention Model: Parallel Assignment
Primary Purpose: Treatment
|Official Title:
|A Randomized, Comparative, Double-Blind Trial of Trimetrexate (CI-898) With Leucovorin Calcium Rescue Versus Trimethoprim / Sulfamethoxazole for Moderately Severe Pneumocystis Carinii Pneumonia in Patients With AIDS
|Estimated Enrollment:
|Study Completion Date:
|September 1991
New treatments are needed to reduce the mortality rate from PCP in AIDS patients and to reduce the high relapse rate found after conventional therapy. Trimetrexate (TMTX) was chosen for this trial because it was found to be much more potent than sulfamethoxazole/trimethoprim (SMX/TMP) against the PCP organism in laboratory tests. Also TMTX, in combination with leucovorin (LCV), did not cause severe toxicity in a preliminary trial. It is believed that TMTX will be more effective than SMX/TMP in treating PCP and in preventing a recurrence of PCP. Preliminary studies suggest that aerosolized pentamidine (PEN) is likely to be effective in preventing a recurrence of PCP.
Patients entered in the study are randomly assigned to TMTX / LCV or to SMX/TMP for a 21-day trial. For the first 10 days, the trial is double-blind (neither patient nor physician knows which drugs the patient is receiving), and drugs are given by intravenous infusion. TMTX is given once every 24 hours and LCV every 6 hours; SMX/TMP is given every 6 hours. Doses are determined by body size. After the first 10 days, LCV and SMX/TMP may be given orally. Doses are adjusted or treatment is changed to intravenous PEN if side effects are too severe. During the 21-day trial, zidovudine (AZT) may not be used because of possible increased bone marrow toxicity. AZT may be resumed as soon as the patient's white cell count is acceptable. Aerosolized PEN therapy is begun 7 - 10 days after completion of therapy for the acute episode. PEN is inhaled once weekly for 4 weeks, then every 2 weeks for 48 weeks.
|Ages Eligible for Study:
|12 Years and older (Child, Adult, Senior)
|Sexes Eligible for Study:
|Accepts Healthy Volunteers:
Inclusion Criteria
Concurrent Medication:
- Acetaminophen:
- 650 mg prescribed as necessary for temperature > 38.7 degrees C. Acetaminophen should not be prescribed as a standing order for more than 48 hours.
Prior Medication:
- Zidovudine (AZT) as long as such therapy is suspended prior to randomization and not reinstituted until therapy for the acute episode is completed and the patient's white blood cell count is acceptable.
- Other myelosuppressive therapies which may be handled in the same manner as AZT.
- Prophylaxis for Pneumocystis carinii pneumonia (PCP).
- Unequivocal diagnosis of Pneumocystis carinii pneumonia (PCP) by morphologic confirmation of three or more typical P. carinii organisms in sputum, bronchoalveolar lavage fluid, or lung tissue obtained by transbronchial or open-lung biopsy within 3 days before or after randomization. If morphologic confirmation is not possible prior to therapy, patients may be randomized if the investigator believes there is a high suspicion of PCP based on clinical presentation. If morphologic diagnosis cannot be established within 6 days of randomization, the patient will be withdrawn from study therapy. Resting (A-a) DO2 < 30 torr on room air. Patient, parent, guardian, or person with power of attorney gives informed consent.
Exclusion Criteria
Co-existing Condition:
Patients will be excluded for the following reasons:
- History of Type I hypersensitivity (i.e., urticaria, angioedema, or anaphylaxis), exfoliative dermatitis, or other life-threatening reaction secondary to antibiotics containing sulfa, trimethoprim, or trimetrexate.
- History of life-threatening pentamidine toxicity.
Concurrent Medication:
- Other drugs for the treatment or prevention of AIDS or Pneumocystis carinii pneumonia (PCP).
- Disalcid.
- Aspirin.
- Acetaminophen q4h as a standing order for more than 48 hours.
Prior Medication:
Excluded within 14 days of study entry:
- Systemic steroids exceeding physiological replacement.
- Other investigational drugs including ganciclovir.
- Excluded within 6 weeks of study entry:
- Another antiprotozoal regimen for this episode for therapy of active Pneumocystis carinii pneumonia (PCP).
- Patients who are unable to have arterial blood gas analysis (ABG's) on room air.
- Patients for whom a liter of intravenous fluid (5 percent dextrose in water) per 24 hours, which is required to maintain blinding, would be medically inadvisable.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00001013
|United States, California
|Los Angeles County - USC Med Ctr
|Los Angeles, California, United States, 90033
|United States, District of Columbia
|George Washington Univ Med Ctr
|Washington, District of Columbia, United States, 20037
|United States, Florida
|Univ of Miami School of Medicine
|Miami, Florida, United States, 331361013
|United States, Illinois
|Northwestern Univ Med School
|Chicago, Illinois, United States, 60611
|United States, Louisiana
|Charity Hosp / Tulane Univ Med School
|New Orleans, Louisiana, United States, 70112
|Louisiana State Univ Med Ctr / Tulane Med School
|New Orleans, Louisiana, United States, 70112
|Tulane Univ School of Medicine
|New Orleans, Louisiana, United States, 70112
|United States, Massachusetts
|Univ of Massachusetts Med Ctr
|Worcester, Massachusetts, United States, 01655
|United States, New York
|Bronx Municipal Hosp Ctr/Jacobi Med Ctr
|Bronx, New York, United States, 10461
|Jack Weiler Hosp / Bronx Municipal Hosp
|Bronx, New York, United States, 10465
|Montefiore Med Ctr / Bronx Municipal Hosp
|Bronx, New York, United States, 10467
|SUNY / Erie County Med Ctr at Buffalo
|Buffalo, New York, United States, 14215
|City Hosp Ctr at Elmhurst / Mount Sinai Hosp
|Elmhurst, New York, United States, 11373
|Beth Israel Med Ctr / Peter Krueger Clinic
|New York, New York, United States, 10003
|Mount Sinai Med Ctr
|New York, New York, United States, 10029
|Univ of Rochester Medical Center
|Rochester, New York, United States, 14642
|SUNY - Stony Brook
|Stony Brook, New York, United States, 117948153
|SUNY / State Univ of New York
|Syracuse, New York, United States, 13210
|United States, Ohio
|Holmes Hosp / Univ of Cincinnati Med Ctr
|Cincinnati, Ohio, United States, 452670405
|Univ Hosp of Cleveland / Case Western Reserve Univ
|Cleveland, Ohio, United States, 44106
|United States, Pennsylvania
|Milton S Hershey Med Ctr
|Hershey, Pennsylvania, United States, 170330850
|Thomas Jefferson Med College
|Philadelphia, Pennsylvania, United States, 19107
|United States, South Carolina
|Julio Arroyo
|West Columbia, South Carolina, United States, 29169
|Study Chair:
|Sattler FR
|Responsible Party:
|National Institute of Allergy and Infectious Diseases (NIAID)
|ClinicalTrials.gov Identifier:
|NCT00001013 History of Changes
|Other Study ID Numbers:
11005 ( Registry Identifier: DAIDS ES Registry Number )
|Study First Received:
|November 2, 1999
|Last Updated:
|March 15, 2012
Keywords provided by National Institute of Allergy and Infectious Diseases (NIAID):
Trimethoprim-Sulfamethoxazole Combination
AIDS-Related Opportunistic Infections
Pneumonia, Pneumocystis carinii
Infusions, Intravenous
Drug Therapy, Combination
Folic Acid Antagonists
Acquired Immunodeficiency Syndrome
Antiprotozoal Agents
AIDS-Related Complex
Additional relevant MeSH terms:
HIV Infections
Pneumonia, Pneumocystis
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases
Lung Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Lung Diseases, Fungal
Pneumocystis Infections
Calcium, Dietary
Trimethoprim, Sulfamethoxazole Drug Combination
Bone Density Conservation Agents
Physiological Effects of Drugs
Protective Agents
Vitamin B Complex
ClinicalTrials.gov processed this record on September 21, 2017


text:
The College of Idaho biology program offers a research-based curriculum taught by faculty who are committed to mentoring and engaging students in the process of science. Consistent with the liberal arts tradition, our faculty's objectives are to give students a strong foundation in the natural and biological sciences, to prepare them for science-based careers, and to enhance their appreciation and understanding of life on earth.
Why study biology at The College of Idaho?
Our biology majors emphasize breadth of experience but also allow students to pursue their own areas of interest within the field of biology. Small class sizes and the accessibility of the C of I's biology faculty provide opportunities not usually found at larger colleges and universities. The department offers a major in biology and biology coursework is incorporated into the College's interdisciplinary environmental studies and health sciences majors. Minors are offered in biology, health professions studies, human biology, natural sciences, and technical and analytical skills in the natural sciences. Within health profession studies, students can choose from eight tracks of study, including pre-med, pre-dental, pre-veterinarian and pre-physical therapy.
Fieldwork and laboratory research are important components of the C of I biology program. The College is located near mountain and desert habitats which provide numerous study sites for student research. Field trips to Australia, Costa Rica, Florida, Hawaii, Death Valley, the Oregon coast and other off-campus sites offer opportunities for hands-on, in-depth learning. In addition, the recently renovated Boone Science Hall contains modern molecular, cellular, organismal and environmental laboratories for research and experimentation. Students interested in health care or in laboratory research work closely with C of I professors to study a variety of topics ranging from human anatomy to molecular biology. Students are encouraged to participate in internships in their areas of interest; these open doors for career opportunities after graduation.
Other resources available to our biology students include the Orma J. Smith Museum of Natural History and the Harold M. Tucker Herbarium. The department also has a variety of cooperative programs with University of Idaho and Idaho State University in areas including resource management, nursing and physical therapy.
Career opportunities for biology majors
The possibilities are endless for C of I biology graduates. Our alumni include the co-discoverer of vitamin B12 and many successful doctors, dentists, physical therapists, veterinarians, pharmacists, researchers, botanists, zoologists, professors and scientists. Department graduates enjoy a high placement rate into graduate school, and many undergraduates get a head start on their research careers through grant-funded faculty-student research programs such as INBRE (IDeA Network of Biomedical Research Excellence) and SWITCH (Southwest Idaho: The Comprehensive Herbaria). No matter what your scientific field of interest is, a C of I biology degree will prepare you to succeed in graduate school and your chosen career.


text:
Dr. Simon Jordan, an up-and-coming expert in the burgeoning field of mental illness, is engaged by a group of reformers and spiritualists seeking a pardon for Grace. He listens to Grace's story, from her family's difficult passage from Ireland to Canada, to her time as a maid in Thomas Kinnear's household. And as he brings Grace closer to the day she cannot remember, he hears of the turbulent relationship between Kinnear and Nancy, and of the alarming behavior of Grace's fellow-servant, James McDermott. Jordan is drawn to Grace, but he is also baffled by her. What will he find in attempting to unlock her memories? Is Grace a female fiend, a bloodthirsty femme fatale, or is she a victim of circumstances?
©1996 O.W. Toad Limited; (P)1996 Bantam Doubleday Dell Audio Publishing, Bantam Doubleday Dell Audio Publishing, A Division of Random House, Inc.
I was looking for a book that would draw me in and keep me on the treadmill long after my 30 minutes were up; and this was it! It's a fascinating story, well written, well presented, and beautifully narrated. My one regret was that I listened to it; it's the type of book I'd normally save for a special full-day reading on the beach. Mental images from the book have stayed with me long after the book was done. And I found myself really captivated by her story and caring about how she was going to come out in the end
I didn't realized this book was abridged, else I would never have selected it. The story was interesting, but the trouble with abridgements is that I always get the feeling I am missing something. No matter how hard the abridger tries, somewhere during the reading I am left wondering what a certain term referred to and why this first reference sounds like a second reference. Personal preference. Buy this for an interesting story, but you might feel a bit unfulfilled at the end.
A truly compelling story of a young woman, lust, murder, betrayal, mystery, with a twist and the end that will make you gasp. I find myself gushing, and I don't gush easily.
This one will grab you and keep you for the entire production! The last audiobook that took my breath away was "The Secret Life of Bees", and this book is every bit its equal. Wonderfully read and lovingly produced. I have become a huge fan of this author.
Margaret Atwood is always great and this book is characteristic of her sensuously detailed style. Complex and ambiguous, but not confusing, "Alias Grace" intrigues until its disappointing, too neat, ending. Where is Atwood's ambiguity when it counts the most? The narrator was fantastic, giving each character a different voice. I was expecialy delighted with her rendition of Grace's subtle Irish brogue. The only other disappointment was that this book is abridged. Highly recommended.
Wow. What a book, what a performance... As a Margaret Atwood fan, I listened to this book even though it was abridged, and was not disappointed: Highly recommended.
"Typical Atwood"
I really enjoyed this book and listened to it twice. However, I did feel slightly "cheated" and wished for the unabridged version because I felt I was missing details so I gave it a 4 instead of a 5. If you can get your hands on the unabridged version, I would definitely recommend it. If not, you will still enjoy it.
The narrator was good.
"Alias Grace"
I think this book and the narration is so good, I'm listening to it again....
"Alias Grace"
Very well written and kept the reader wondering what really happened.
Addicted to audiobooks & podcasts. 5 Stars=I Loved It, 4 Stars=Enjoyed it Thoroughly, 3=Kinda Good, 2=Bad/Boring, 1=Complete Waste of Credit
"Solid story - good listen"
This is my 2nd selection by Margaret Atwood and so far I really enjoy the flow and style of her writing. This is a straightforward story of a girl imprisoned for murder who just might have been innocent. Great narrator - she does a good job of portraying the innocence of the main character. I enjoyed this book and will be shopping for more titles by this author.
"Alias Grace"
Amazingly wonderful.
Report Inappropriate Content
If you find this review inappropriate and think it should be removed from our site, let us know. This report will be reviewed by Audible and we will take appropriate action.


text:
Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Recruitment status was: Active, not recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which regimen of chemotherapy is more effective for non-small cell lung cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of two regimens of chemotherapy in treating patients who have stage IIIB or stage IV non-small cell lung cancer.
|Lung Cancer
|Drug: cisplatin Drug: gemcitabine hydrochloride Drug: vinorelbine tartrate
|Phase 3
|Study Type:
|Study Design:
|Allocation: Randomized
Primary Purpose: Treatment
|Official Title:
|Gemcitabine and Vinorelbine vs Standard Chemotherapy Containing Cisplatin for Stage IIIB/IV Non-Small Cell Lung Cancer
|Study Start Date:
|November 1998
OBJECTIVES: I. Compare gemcitabine plus vinorelbine vs standard chemotherapy containing cisplatin in terms of the effect on the quality of life of patients with stage IIIB or IV non-small cell lung cancer. II. Compare the effect of these regimens on the overall survival of these patients. III. Compare the toxic effects of these regimens in these patients. IV. Compare the effect of these regimens on the rate of objective response in these patients.
OUTLINE: This is a randomized, multicenter study. Patients are stratified according to center, stage of disease (IIIB vs IV), and performance status (0 vs 1 vs 2). Patients are randomized to one of two treatment arms. Arm I: Patients receive cisplatin IV on day 1 and either gemcitabine IV or vinorelbine IV on days 1 and 8. Arm II: Patients receive gemcitabine IV and vinorelbine IV on days 1 and 8. Treatment repeats every 21 days for up to 6 courses. Quality of life is assessed prior to therapy and before each course of chemotherapy to the fourth course.
PROJECTED ACCRUAL: A total of 500 patients will be accrued for this study.
|Ages Eligible for Study:
|up to 69 Years (Child, Adult, Senior)
|Sexes Eligible for Study:
|Accepts Healthy Volunteers:
DISEASE CHARACTERISTICS: Histologically or cytologically proven non-small cell lung cancer Stage IV OR Stage IIIB with supraclavicular lymph node metastases and/or pleural effusion that is not curable with radiotherapy Measurable or evaluable disease No CNS metastases
PATIENT CHARACTERISTICS: Age: Under 70 Performance status: ECOG 0-2 Life expectancy: Not specified Hematopoietic: Neutrophil count at least 2000/mm3 Platelet count at least 100,000/mm3 Hemoglobin at least 10 g/dL Hepatic: (Unless caused by liver metastases) Bilirubin no greater than 1.25 times upper limit of normal (ULN) SGOT or SGPT no greater than 1.25 times ULN Renal: Creatinine no greater than 1.25 times ULN Other: No prior or concurrent malignancy except basal or squamous cell skin cancer or carcinoma in situ of the cervix
PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: No prior chemotherapy Endocrine therapy: Not specified Radiotherapy: See Disease Characteristics Concurrent palliative radiotherapy allowed Surgery: Not specified
Please refer to this study by its ClinicalTrials.gov identifier: NCT00004100
|Ospedale San Lazzaro
|Alba, Italy, 12051
|Ospedale Civile Avellino
|Avellino, Italy
|Ospedale G. Di Maria - Avola (SR)
|Avola (SR), Italy
|Azienda Ospedaliena G. Rummo
|Benevento, Italy, 82100
|Ospedale Cardarelli - Campobasso
|Campobasso, Italy
|Ospedale Civile Cosenza
|Cosenza, Italy, 87100
|Ospedale San Martino/Cliniche Universitarie Convenzionate
|Genoa, Italy, 16132
|Ospedale Gen. Provinciale Santa Maria Goretti
|Latina, Italy, 04100
|Ospedale di Legnano
|Legnano, Italy, 20025
|Ospedale Maggiore Lodi
|Lodi, Italy, I-20075
|Istituto Di Science Biomediche San Paolo
|Milano, Italy, 20142
|Ospedale Di Gabargnate Milanese
|Milan, Italy, 20024
|Ospedale San Carlo Borromeo
|Milan, Italy, 20153
|Federico II University Medical School
|Naples, Italy, 80131
|Istituto Nazionale per lo Studio e la Cura dei Tumori
|Naples, Italy, 80131
|Ospedale S. Gennora USL 42
|Naples, Italy, 80136
|Ospedale Vincenzo Monaldi
|Napoli, Italy, 80131
|ASL 2 - Napoli
|Napoli, Italy
|Universita di Palermo
|Palermo, Italy, 90141
|Ospedale La Maddalena - Palermo
|Palermo, Italy
|Ospedale S. Francesco - Paola
|Paola (CS), Italy
|Ospedale Agnelli
|Pinerolo, Italy, 10064
|Ospedale San Carlo
|Potenza, Italy, 85100
|Ospedali Riuniti
|Reggio Calabria, Italy, 89100
|Rho, Italy
|Ospedale Oncologieo G. Fortunato
|Rionero, Italy
|Istituti Fisioterapici Ospitalieri - Roma
|Rome, Italy, 00161
|Ospedale Civile - Rovereto
|Rovereto, Italy
|Ospedale San Bortolo
|Vicenza, Italy, 36100
|Study Chair:
|Cesare Gridelli, MD
|Istituto Nazionale per lo Studio e la Cura dei Tumori
|Study Chair:
|Vera Hirsh, MD, FRCPC
|Royal Victoria Hospital - Montreal
|ClinicalTrials.gov Identifier:
|NCT00004100 History of Changes
|Other Study ID Numbers:
|Study First Received:
|December 10, 1999
|Last Updated:
|December 17, 2013
Keywords provided by National Cancer Institute (NCI):
stage IIIB non-small cell lung cancer
stage IV non-small cell lung cancer
Additional relevant MeSH terms:
Lung Neoplasms
Carcinoma, Non-Small-Cell Lung
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Lung Diseases
Respiratory Tract Diseases
Carcinoma, Bronchogenic
Bronchial Neoplasms
Antineoplastic Agents
Antimetabolites, Antineoplastic
Molecular Mechanisms of Pharmacological Action
Antiviral Agents
Anti-Infective Agents
Enzyme Inhibitors
Immunosuppressive Agents
Immunologic Factors
Physiological Effects of Drugs
Antineoplastic Agents, Phytogenic
ClinicalTrials.gov processed this record on September 21, 2017


text:
I bought a 310 TL along with a 15 degree Cleveland FL fairway wood used from Global Golf. I don't thing I will ever purchase a new driver or 3 wood again. I went kind of cheap and bought both of the woods in the Very Good standard. There were a few marks on the club but nothing too big. They look as if they have been hit on the mats at a driving range. I originally bought a 270xl model driver and did not like it. I sent it back and they sent me a 310tl, the only problem with that I had to pay for the shipping to send it back. Overall I am satisfied with my used clubs and will be using this website again. Thanks!
I bought the 3+ FW and sent it back due to the fact I can hit a 2 hybrid mashie further ~210 vs ~225 respectively. The mashie is also alot easier to hit. As for Global Golf they're great!
Feeling lucky about finding this excellent 3 wood "cannon"! Real nice shape and GREAT low price.Beautiful club


text:
Convicted drunk driver employed by government to drive van
SEATTLE -- Your tax dollars are paying the salary of a convicted drunk driver who's crashed his private car, twice, while intoxicated.
That same government worker is now driving an agency car on the streets of Seattle. All of this was uncovered in a KOMO 4 Problem Solver "What a Waste" investigation.
That driver is Art Cochran. He's a plumber working for the taxpayer-funded Seattle Housing Authority. His job, like every other plumber working for SHA, requires him to drive to various Housing Authority apartment buildings around the city where he does plumbing maintenance.
But Cochran has a problem: he has a history of drinking and driving. We caught up with him one morning as he was starting work and asked him about his DUI arrests. His response was short and to the point: "well I'm not supposed to speak to the media."
Cochran's drunk driving history began in 2002 when court records show he crashed his car in a ditch and had a blood alcohol reading of .18 which is more than twice the legal limit.
Cochran was charged with DUI, but pled guilty to reckless driving. The court sentenced him to two days in jail and required him to attend a Victim's Panel. But we found he was kicked out of that panel for showing up with alcohol in his system.
When we asked about that he told us, "never happened." But again, the court records show he blew a .05 at that meeting.
The whole scenario is concerning for Mothers Against Drunk Driving. Washington State MADD manager Amy Ezzo.
"Impaired driving impacts every single one of us," Ezzo said.
Over the past year, a series of horrific fatal crashes in Seattle have brought the high cost of drunk driving to the forefront and forced changes in state law. But those changes happened after the Cochran case.
MADD wouldn't talk specifically about Cochran's case. However, they told us that, in general, by the time someone's arrested they typically have a long history of driving drunk.
"Before they get arrested," Ezzo said. "They've driven about 80 times while impaired."
In Cochran's case, his 2002 arrest was followed by a second in November of 2011 when he crashed his car into a pole. His blood test showed a .19. That's nearly two and a half times the legal limit. Despite a pending criminal case on that charge and the prior alcohol-related crash, Cochran continued driving Housing Authority vans with no restrictions for 15 months.
We asked why SHA would allow Cochran to continue driving like that. SHA Spokeswoman Michelle Ackerman told us SHA takes such cases very seriously and has a team of people who examine employee driving records whenever an incident occurs.
"We take very strong precautions to make sure that they're not going to be driving drunk or even had something to drink much less drunk while they're driving one of our vehicles," she said.
SHA finally took Cochran off the streets after he was sentenced last February and his license restricted him to driving vehicles with an ignition interlock. SHA confirmed to the Problem Solvers that Cochran continued to get paid for and perform the work of a senior plumber.
But our sources told us he was doing entry level manual labor. When the Problem Solvers went undercover, we found Cochran moving furniture and doing yard work.
Then, last August, SHA put Cochran back behind the wheel and back on the streets. The Housing Authority claims that's acceptable since Cochran paid for and installed an ignition interlock device on one of its vans.
We asked Cochran himself if he thought it was reasonable for him to be driving an SHA-owned, taxpayer-funded van with two DUI arrests on his record. Again, he declined to comment.
We also asked SHA's Ackerman why they'd ever let an employee drive with that type of record.
"Well we take every precaution and certainly in this case we did that," Ackerman said.
SHA has about 175 employees who drive as part of their jobs. Ackerman said the agency has a very good safety history and that drivers' records are examined at least once a year.
The Problem Solvers did some digging and discovered that Cochran is protected under civil service rules that limit what city agencies can do when it comes to employees with a valid drivers license and asked Ackerman if that prohibits them from firing someone.
"Certainly there are different circumstances that apply to different types of employment and we need to take those into consideration," she said.
So Art Cochran continues to drive a Housing Authority van on Seattle streets -- and taxpayers are footing the bill.
Until the new state law passed this year, drunk drivers didn't have to install an interlock device until they were convicted. Now drivers with any impairment history are required to get an interlock device within five days of their arrest for DUI.


text:
The premiere destination for art culture enthusiasts...
For a great selection of action figures and collectibles, check out BigBadToyStore.com, Urban-Collector.com, BriansToys.com, ClarkToys.com, ToyWiz.com, SmallJoes.com, VNCToys.com, PastGenerationToys.com, MonkeyDepot.com, RPMDiecast.com, YesAnimation.com, and SuperheroToys.com.
For a great selection of pop culture t-shirts and apparel, check out TShirtGurus.com.
Housed in the comfortable 25,000 square foot hall in Pasadena, CA, DesignerCon showcased the various aspects of art and design; from collectible toys, custom figures, and designer apparel to urban, underground, and pop art. DesignerCon was formerly known as the Vinyl Toy Network and has been the premiere destination for art culture enthusiasts since 2006.
This year's exhibition brought some of the most exciting contemporary artists together in one hall. Los Angeles artist Buff Monster joined the show for the very first time this year and created limited-edition capsule collections of custom figures and silkscreen prints. Artists Joe Ledbetter and Sam Flores also debut exclusive figures for the show. Paul Kaiju was available to release his Partyball figure at Super7.
It truly was a great event as over twenty artists were in attendance this year including Tim Biskup, Amanda Visell, Greg "Craola" Simkins, Robert Goodin, Nathan Hamill, and many more. Many familiar brands were also on hand to bring the vinyl toy store to you, including, but not limited to Blamo, Super 7, Baby Tattoo, JapanLA, Munky King, Beautiful Decay, Mr. Toast, and Toy2R.
Of course one of the main highlights was the Custom Yoka show, presented by DKE Toys and adFunture. DKE Toys co-founders Dov Kelemer and Sarah Jo Marks provided their 3" blank Yoka bear vinyl figures to over 200 artists to customize. The results were shocking, awe-inspiring, and often hilarious.
There was a whole lot more to see and do at DesignerCon of course. Sponsored by organic Y Water, the event was only $5 for adults and free for children 13 and under.
For more information about DesignerCon, the artists and exhibitors, please visit www.designercon.com.
Please browse through our PHOTO GALLERY for just a glimpse of what DesignerCon 2009 had to offer!
-David Yeh


text:
Welcome to AccountsReceivableLoans.com
Welcome to AccountsReceivableLoans.com your #1 source for finding the best Factoring Companies nationwide that can provide you with Accounts Receivable Loans, Accounts Receivable Factoring, Receivable Financing, or Small Business Loans.
Factoring Companies can provide you with the working capital you need to meet your obligations and grow your business. Financing the growth of your business can be a challenge. New businesses that do sales on credit terms may eventually need additional working capital. If your sales have created a cash flow shortage in your business, then your company may be able to benefit from accounts receivable financing.
Accounts receivable lenders and Factoring Companies specialize in financing growing businesses. Lending on accounts receivable is the advancing of funds against your accounts receivable. Accounts receivable lending is not a loan, it's an advance or purchase of your
receivables, so there's no need to make payments or create debt to your business. When you receive an accounts receivable loan, the lender uses your company's accounts receivable as collateral. You then repay the loan as your customers pay their receivables.
Whether you need help with Accounts Receivable Financing, Accounts Receivable Factoring, Invoice Purchasing, Purchase Order Financing, Asset-Based Lending, Post Bankruptcy Factoring, or Invoice Factoring, AccountsRecivbaleLoans.com can help. Connect with hundreds of top local Factoring Companies nationwide.
You'll save time and money by using AccountsReceivableLoans.com. Not sure what type of Factoring or Financing you need? Need to find out if Accounts Receivable Financing is right for your company? Visit our Learning Center and find answers to many of the questions that you may be searching for. Let AccountsReceivableLoans.com help you get the financing you need.Source: accountsreceivableloans.com
Category: Forex
Similar articles:
How should investors interpret accounts receivable information on a company's balance sheet?
3 common accounts receivable mistakes and how to fix them


text:
The "First Avenger" in his red, white and blues...
For a great selection of superhero action figures and collectibles, check out fine sponsors BigBadToyStore.com, BriansToys.com, ToyWiz.com, ToyDorks.com, PastGenerationToys.com, Urban-Collector.com, SmallJoes.com, HobbyLinkJapan.com, and Sekaido.com.
To insure your action figure collection, get in touch with our sponsor Collectibles Insurance.
Marvel is finally raising the curtains on the upcoming Captain America film and giving the public a good look at what the First Avenger will look like in the upcoming film. The latest issue of Empire features Chris Evans all decked out in his star-spangled outfit on the cover and also reveals many details inside including a first look at actor Hugo Weaving as the Red Skull and a new image of a fully-masked Captain America.
Capatain America :The First Avenger opens nationwide in theatres July 22nd 2011. The first official movie trailer is expected to air during the Super Bowl this Sunday.


text:
Security Consulting
Strategic Infrastructure Security
Comprehensive and Methodical
We help organizations protect themselves by providing expertly executed and meaningful services focused on assessing the underlying infrastructure of an organization. Composed of systems, servers, networks, buildings and people, infrastructure contributes the majority of an organization's attack surface.
Security Defense Operations
How effectively could you respond when an incident occurs?
Mature organizations realize that security incidents cannot be completely avoided. Preparing for incidents and successfully dealing with their consequences is a key part of risk management in the modern world.
Application Security
Unrivaled Experience
We provide discerning clients with high-end application services including penetration testing, code review, design review, architecture review, threat modeling and Secure Development Lifecycle creation.
Mobile Security
Trusted Experts
We have deep a understanding of mobile architectures and application development, having assessed many mobile applications, assisted organizations in leveraging mobile development security best practices, and reviewed device-level security controls while working with OEMs and telecommunications providers.
Cryptography Services
Leading provider of security assessments
We have a wealth of experience building, breaking, fixing and deploying cryptographic solutions that our customers rely on for their core business, data protection, compliance and security needs.
Keyhole Service
Security Baseline for Applications
A light-touch, fast, analyst-driven web application penetration test geared towards those smaller applications that never get a full assessment but still represent a threat.
Bug Bounty Support Program
Triage Specialists
In response to popular demand, NCC Group is pleased to present our Bug Bounty Support Program.
Managed Security Services
How do you assure your security inbetween penetration tests?
Our Managed Security Services can dramatically improve your ongoing security posture through more frequent, cost effective security assessments, helping you to identify, assess and manage risk.
With most organisations still opting to conduct penetration tests once a year there are potentially significant periods for new vulnerabilities to be introduced.
Risk Management & Governance
Experience and Know-How
We deliver a systematic and strategic approach, essential in the modern compliance landscape. We are a PCI qualified security assessor and approved scanning vendor, as well as an ISO 27001 accredited organization.
Training Services
Security Experts
The moving target of computer security is hard to hit, even for seasoned security practitioners. Without good and relevant training that is continuously reinforced and updated, it is easy to get behind the threat curve and make mistakes.
- NCC Group highlighted in Gartner Managed Detection and Response report
- NCC Group highlighted in Gartner Operational Technology report
- NCC Group highlighted in Gartner Operational Technology report
- Healthcare Info Security: Clinic Discovers Lengthy Intrusion Post-Ransomware Attack
- Netzpolitik: How to pique your curiosity in cryptography


text:
AFTER 20 YEARS, the Lynn Woolsey era in Congress officially ends today.
Jared Huffman now occupies her seat in the House, representing a district that includes Marin and other counties on the North Coast.
Woolsey, 75, joined Congress in the "Year of the Women" along with Sens. Barbara Boxer and Dianne Feinstein.
Woolsey entered the House as a liberal and stayed there for 20 years, eventually leading the Congressional Progressive Caucus for six.
She obviously represents a liberal congressional district, one of the safest Democratic seats in the House. She regularly received more than 70 percent of the vote.
In an interview with IJ reporter Richard Halstead in her Petaluma home last month, Woolsey said it was time to retire and that she has no regrets. "I'm not walking out of here saying, 'Oh, I wish I'd done more.' I couldn't have done more."
Those words say much about Woolsey, who quickly figured out who she was and wasn't in Washington, D.C., and grew increasingly comfortable in her political skin as the years passed.
She was never a power broker.
She never forgot that she was once a single mom on welfare. (President Bill Clinton even singled her out for overcoming those tough times during his second State of Union of address in 1996.)
She voted her conscience (even if she skipped the final vote on the fiscal cliff on Jan.1).
She was consistent and authentic, even if some of her colleagues and constituents viewed her as tilting at windmills at times.
She was steadfast in her opposition to the wars in Afghanistan and Iraq. She gave 444 speeches on the House floor (often to a nearly empty chamber) in opposition to those wars.
And she kept getting re-elected.
Perhaps that was because her integrity was taken for granted as years rolled by.
Could she have done more in Congress? Of course. But does it really matter that she didn't? That depends on your perspective.
She was true to her ideals and convictions and was not seduced or corrupted by power despite being at the epicenter of temptation for 20 years.
That is an impressive legacy.
She will not truly retire. But you won't see her cashing in on her time in Washington.
She plans to focus on activism as national president of Americans for Democratic Action. She will take on a new role at CARE, the global humanitarian organization.
We commend Lynn Woolsey for 20 years of dedicated service to the North Bay and applaud her for what she plans to do in the next phase of her life.


text:
Sign into our member site to view your information online.Forget your username or password? Not registered? Register here
mifepristone (generic name)
It is used in combination with other medicines to end an early pregnancy (usually during the first 7 weeks)
(mi FE pri stone)
Table of Contents
Top Learning Centers(Recursos en Español)
What is this medicine?MIFEPRISTONE (mi FE pri stone) is a hormone-like drug. It is used in combination with other medicines to end an early pregnancy (usually during the first 7 weeks). This medicine is only available in a doctor's office, health clinic, or hospital.
What should I tell my health care provider before I take this medicine?They need to know if you have any of these conditions:
How should I use this medicine?Take this medicine by mouth with a glass of water. Follow the directions on the prescription label. Before you take this medicine, read the information your doctor or health care provider gives you. Talk to your doctor about any questions you have. Take your medicine exactly as directed. Do not take your medicine more often than directed. Do not stop taking except on your doctor's advice.
A special MedGuide will be given to you by the pharmacist with each prescription and refill. Be sure to read this information carefully each time.
Talk to your pediatrician regarding the use of this medicine in children. This medicine is not approved for use in children.
What if I miss a dose?This does not apply.
What may interact with this medicine?Do not take this medicine with any of the following medications:
This medicine may also interact with the following medications:
What should I watch for while using this medicine?For your safety, you must visit your doctor as directed after taking this medicine. Report any unusual effects to your doctor. This medicine can cause birth defects. You will need surgery if this medicine fails to cause a full abortion.
After you take this medicine, some vaginal bleeding is normal. Heavy bleeding may be a sign that something is wrong. If you soak through 2 thick full-size sanitary pads each hour for 2 hours, get medical help right away. Tell the health care provider that you have taken this medicine.
Call your doctor if you have a fever, stomach pain or tenderness, nausea, vomiting, diarrhea, or feel weak. This may be a sign that something is wrong. You may have a serious infection or complication and need medical help.
Keep the MedGuide for this medicine. If you need emergency medical care, show your healthcare provider the MedGuide.


text:
Robertson & Wood
Castle And Town, Chapters In The History Of The Royal Burgh Of Edinburgh
published by Oliver And Boyd, Edinburgh & London, 1928; First �
Edition; "good" only pale blue-grey cloth hardback; no dustwrapper;
16 X 23 cm; 316 p............ Read More
Dear Browsers,
Andrew's well-published "do" for Record Store Day went down extremely well on Saturday; congratulations & 'likes' are still popping onto
our FaceBook page at https://www.facebook.com/ParkinsonsBooks/ The shop was heaving all day and then on into Sunday with swarming
turntable fans. Swarms more have visited, browsed and bought well into the week. (Jazz has sold particularly well.) We owe a big "thank you"
also to our local newspaper The Southport Visiter http://www.southportvisiter.co.uk/ for all the publicity they gave not only to
us but to other shops in the area celebrating vinyl. All our participating DJs deserve a sizeable dollop of gratitude too.
And --- to change the subject totally --- Sunday was a bumper day for large tropical shell. We now have only one natural Nautilus shell
left and just two pearlised ones. One v. big & beautiful Triton's Trumpet Charonia tritonis and two magnificient specimens of
the Great Yellow Helmet Cassis cornuta still grace the shelves.
Joan's recent acquisition of miniature hindu deities has gone down well.
To add to the week's variety a newly acquired collection of 19th. C. prints of
chicken breeds is queuing up to be sorted & priced.
After many long hours of patient work by Andrew and Liam, the bargain ginnel is now well-lit
and the shop porch is water-proofed and partly re-plastered --- more room for even more quirky stock.
During the working week we try to jot down here some of the frequent changes to the website and shop.
britblog mainblog
We hope you are tempted to explore a few more pages.
Please recommend us to your friends.
Joan, Tony & Andrew Parkinson
Your browser does not support iframes.


text:
Becker Continued Access Study
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
While Core Becker patient follow-up is being completed this Continued Access Study is designed to enroll patients at a limited rate per month to allow for continued physician and patient experience with the device.
Up to 12 patients per month at sites across the United States will be enrolled in this research study. These patients will be implanted with the Becker 25 or Becker 50 Expander/Breast implant and monitored for 10 years for safety.
|Breast Reconstruction
|Device: Mentor Becker 25 Expander/Breast Implant Device: Mentor Becker 50 Expander/Breast Implant
|Phase 3
|Study Type:
|Study Design:
|Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
|Official Title:
|Continued Access Study of the Mentor Becker Expander/Breast Implant
- Safety will be determined by incidence, severity, method of resolution, and duration for all adverse events on a per implant and per subject basis [ Time Frame: 10 Years ]
|Study Start Date:
|June 2009
|Estimated Study Completion Date:
|November 2020
|Estimated Primary Completion Date:
|November 2020 (Final data collection date for primary outcome measure)
|Assigned Interventions
The study population will consist of women aged 18 or over who are undergoing primary breast reconstruction.
The Reconstruction cohort will include subjects with loss of breast tissue due to mastectomy, contralateral breast for post-reconstruction symmetry or subjects with deformities secondary to disease, malignancy, trauma, and congenital deformity. Subjects in this cohort cannot have been implanted with breast implants, but may have tissue expanders. A Becker implant is considered a tissue expander until the port and fill tube have been removed. Women who undergo surgery primarily for a mastopexy will not be part of the reconstruction cohort.
Device: Mentor Becker 25 Expander/Breast Implant
Device: Mentor Becker 50 Expander/Breast Implant
The breast implant is comprised of the Becker implant and the injection dome/fill tube and has a low bleed, gel-filled outer lumen and an adjustable saline-fillable inner lumen. The inner lumen can be gradually filled with saline over an extended period of time via the fill tube by injecting saline through the injection dome. Once expanded to the desired volume, the fill tube and injection dome are removed through a small incision under local anesthetic, and the prosthesis remains in position as a breast implant.
The Becker 25 Expander/Breast Implant has a silicone gel volume of approximately 25% and saline volume of approximately 75%. The Becker Expander/Breast Implant is available in sizes 150 - 800cc.
The breast implant is comprised of the Becker implant and the injection dome/fill tube and has a low bleed, gel-filled outer lumen and an adjustable saline-fillable inner lumen. The inner lumen can be gradually filled with saline over an extended period of time via the fill tube by injecting saline through the injection dome. Once expanded to the desired volume, the fill tube and injection dome are removed through a small incision under local anesthetic, and the prosthesis remains in position as a breast implant.
The Becker 50 Expander/Breast Implant has a 50% gel volume and a 50% saline volume, so a 400cc implant would nominally have 200cc of saline and 200cc of silicone. The Becker 50 Expander/Breast Implant is available in sizes from 300 to 700cc.
Detailed Description:
Silicone gel-filled breast implants were introduced in the early sixties and were in wide-scale distribution by the time the Medical Device Amendments to the Food Drug and Cosmetic Act was passed in 1976. In 1983, gel-filled breast implants were designated as Class III devices requiring premarket approval. In May 1990, the Food and Drug Administration (FDA) published a proposed request (515(b)) for Pre-market Approval Applications (PMA) and in April 1991 published the final request. This final publication put manufacturers of gel-filled breast implants on notice that for continued marketing of gel-filled breast implants, a PMA was due to FDA in 90 days from the final publication date.
A pre-market approval (PMA) for the Mentor gel-filled breast implants was filed with the FDA in July 1991. At the FDA General and Plastic Surgery Advisory Committee meeting in November 1991, the committee recommended the submission of additional information to establish the safety and effectiveness of gel-filled breast implants.
In January 1992, the FDA Commissioner announced a voluntary moratorium of the sale of gel-filled breast implants to allow the advisory panel time to assess additional information. In April 1992, the moratorium was lifted but only for reconstruction and revision subjects. Every subject implanted had to be part of an adjunct study, in addition to being offered participation in a registry of gel-filled breast implant subjects. In order to be implanted with gel-filled implants for augmentation, women had to be enrolled in an IDE clinical trial.
A PMA for Mentor's MemoryGel™ Silicone Gel-Filled breast implants (which did not include the Becker Expander/Breast Implants) was subsequently filed with FDA in December 2003, and approved in November 2006 (P030053). As a condition of approval of P030053, new enrollment in Mentor's Adjunct Study has ceased, and women no longer have access to the Becker Expander/Breast Implants.
The Mentor Becker Expander/Breast Implant was used throughout the United States during this time (since 1992) under the Mentor Adjunct Study to allow continued access to the device and to collect some safety information, however was not evaluated in the MemoryGel Core Study. The gel fill used in the MemoryGel implants is the same gel fill that is used for the Becker device.
This protocol describes the study design procedures and population for a Continued Access (CA) Study for the Mentor Becker 25 and 50 Expander/Breast implants. While Core Becker patient follow-up is being completed, this CA Study is designed to enroll patients at a limited rate per month to allow for continued physician experience with the device. The safety data obtained may be used to provide supplemental information to the PMA. It will be requested that this study be initiated and renewed every six months until a final decision is reached regarding the Becker PMA.
|Ages Eligible for Study:
|18 Years and older (Adult, Senior)
|Sexes Eligible for Study:
|Accepts Healthy Volunteers:
Inclusion Criteria:
- Subject is genetic female, 18 years of age or older
- A candidate for primary breast reconstruction for cancer, trauma, surgical loss of breast tissue due to mastectomy, malignancy, contralateral post-reconstruction symmetry, or congenital deformity, including asymmetry (see Section 6.0 for definition)
- Signs the Informed Consent
- Agrees to return device to Mentor if explant necessary
- Agrees to comply with follow-up procedures, including returning for all follow-up visits
- Patient is a US citizen with a Social Security Number and understands English
Exclusion Criteria:
- Subject is pregnant
- Has nursed a child within three months of study enrollment.
- Been implanted with any silicone implant including breast implants (e.g. silicone artificial joints or facial implants)
- Confirmed diagnosis of the following rheumatic diseases or syndromes: SLE, Sjogren's syndrome, scleroderma, polymyositis, or any connective tissue disorder, rheumatoid arthritis, crystalline arthritis, infectious arthritis, spondylarthropathies, any other inflammatory arthritis, fibromyalgia, or chronic fatigue syndrome
- Infection or abscess anywhere in the body
- Demonstrates tissue characteristics which are clinically incompatible with implant (e.g. tissue damage resulting from radiation, inadequate tissue, or compromised vascularity)
- Possesses any condition, or is under treatment for any condition which, in the opinion of the investigator and/or consulting physicians(s), may constitute an unwarranted surgical risk
- Anatomic or physiologic abnormality which could lead to significant postoperative adverse events
- Demonstrates characteristics that are unrealistic/unreasonable with the risks involved with the surgical procedure
- Premalignant breast disease without a subcutaneous mastectomy
- Untreated or inappropriately treated breast malignancy, without mastectomy
- Are HIV positive
- Implanted metal or metal devices, history of claustrophobia or other condition that would make a MRI scan prohibitive
- Physician is intending to use the device for tissue expansion only
Please refer to this study by its ClinicalTrials.gov identifier: NCT01286870
|United States, California
|Mentor Worldwide LLC
|Santa Barbara, California, United States, 93111
|Principal Investigator:
|Mark A. Walker
|Binghamton, NY
|Responsible Party:
|Mentor Worldwide, LLC
|ClinicalTrials.gov Identifier:
|NCT01286870 History of Changes
|Other Study ID Numbers:
Becker CA Study
|Study First Received:
|January 27, 2011
|Last Updated:
|October 26, 2015
Keywords provided by Mentor Worldwide, LLC:
Primary Breast Reconstruction
ClinicalTrials.gov processed this record on September 21, 2017


text:
Los Angeles -- CBRE Group said Wednesday that the U.S. commercial real estate market continued to show moderate improvement across all property sectors in third quarter 2012.
In the retail sector, properties continued to see modest improvement in availability, which fell 10 bps to 12.9%, during the third quarter.
"Real estate occupancy continues to improve slowly, mirroring the sluggish economic recovery," said Jon Southard, managing director of CBRE's Econometric Advisors group. "However, local conditions continue to vary widely. The majority of markets did see more space occupied than in the prior quarter, but in many markets, the occupancy increase was not enough to significantly decrease the total space available."
The report found that a majority of the retail markets recorded either flat or declining availability rates compared with second quarter 2012. Notable top performers included Cleveland, Jacksonville, Fla., Bakersfield, Calif., Charlotte, N.C., and Cincinnati. On the bottom end were Las Vegas, Indianapolis, Tampa and Fresno, Calif., which recorded increases in availability rates of at least 50 bps in the third quarter.


text:
Phytophthora root and stem rot is showing up in soybeans in South Dakota again this year as evidenced by portions of fields with poor stand establishment as well as large numbers of wilting and dying plants. The main cause of wilted plants around this time (flowering) is Phytophthora root and stem rot. Phytophthora root and stem rot is one of the most damaging diseases of soybeans in South Dakota. This disease is caused by a fungal pathogen, Phytophthora sojae, a fungus like microorganism that survives in the soil and in infected residue. Infection is favored by poor drainage especially in heavy clay soils and compacted soils. Low wet spots in the field entrance areas have a higher percentage of infected plants (Fig. 1).
P. sojae and closely related fungal like microorganisms commonly infect at the seedling stage, causing pre-emergence damping off, seed rot as well as post-emergence damping off and seedling blight, pre-damping or post-damping off can occur. Infected plants at this phase will be clearly visible in low areas of fields, but may also be hidden underneath the canopy of nearby plants within the row. (Additional information on seedling diseases may be obtained in the iGrow article: Scout For Seedling Diseases)
Plants that have emerged and escaped damping-off may still be infected and will later show root and stem rot. Infection starts in the roots and progresses upwards on stem above the soil line. A characteristic symptom of the stem rot phase is a dark brown color on the stem and lower branches (Fig. 2). By this time, roots will be rotted and the infected plants can easily be pulled from the soil. Often plants with the stem rot phase of the disease will still have a functional tap and major lateral roots and cannot be easily pulled from the ground. Symptom progression up the stem will depend on susceptibility of the variety as well as time of infection, soil type, and weather conditions. (Fig. 3).
Management of Phytophthora root and stem rot is difficult in part due to many genetic forms (physiological races) of the pathogen. Over 50 races of this fungus occur in North America. Many of these races are found in South Dakota. Most of the genes that have been incorporated into soybean for resistance to Phytophthora are vulnerable to races found in South Dakota, including Rps1k. Variety selection based on knowledge of races in a particular field would be helpful, but this is not possible for most South Dakota farmers. Farmers should keep a good history of their fields prone to Phytophthora, so that they may judge the effectiveness of resistance genes in their varieties.
In the absence of specific information for fields with recurring Phytophthora issues, current strategy would be to plant varieties with Rps1k, Rps3a, Rps6 or a combination thereof (stacked). Farmers should also try to select varieties with higher levels of field tolerance, which is a general non-race specific type of resistance. Most seed catalogues will have a field tolerance rating for Phytophthora. Since resistance genes for Phytophthora are vulnerable to defeat from new emerging races, farmers should not depend solely on major gene resistance. Therefore integrating several management strategies is necessary for effective management of this disease.
Improving drainage (avoiding soil compaction and draining wet spots) lessens chances of Phytophthora infection. Fungicide seed treatment is recommended for fields with a known history of damping-off (see the Soybean Seed Treatments section of the 2013 South Dakota Soybean Crop Protection Guide publication). Use of fungicides as an in-furrow or banding application, although effective, has not generally been incorporated into soybean production because of product costs.


text:
Why Study English?
Our course offerings stress the intensive study of writers and their works in literary, cultural, and historical contexts and strike a balance between great authors of past centuries and emerging fields of study. Our creative writing courses, including screenwriting and creative nonfiction, provide the opportunity for students to develop their own creative work and a diversity of writing styles. Each English major works with her advisor to design a program appropriate to her interests (and that fulfills the department's requirements) to create a coherent intellectual experience and deepen one's understanding of a particular period or genre of writing. In the process, our majors gain an understanding of the power, history, and creative potential of language, and develop critical thinking skills, clear and effective writing skills, and the ability to construct and defend an argument.


text:
Add me on facebook @ michael Adewale holar
I Luv Nicki Minaj lyk so much.....she is my idol
Wed, Jul 25, 2012 at 10:40 PM
Nicki's Tatoo
Nicki Minaj has one of the more interesting Chinese tattoos out there. It's not particularly pretty (it was clearly not the ink work of a Chinese calligrapher!), but thetraditional characters are correct mostly correct and legible. The tattoo: It means "God is with you." The tattoo uses traditional Chinese characters: ?? ? ? ? ? Here's the simplified characterversion (it only...


text:
Hell Creek on Heels 5k and 10k Trail Run
Wilson Lake State Park, Kansas
Sun 04/14/2013
5K, 10K, Trail
30 Participants
Go checkout Facebook Switchgrass Trail for pictures, videos, maps, and rave reviews of our IMBA Epic trail!!! The closest town to Wilson State Park is Wilson, KS. The race is NOT in Wilson. The race is at Wilson State Park, Hell Creek Area, Switchgrass Trailhead, located 5 miles North of Wilson, KS Directions: In central Kansas, on I-70, take Exit 206 N (Wilson), then drive north 5 mi on K-232, then west on Shoreline Dr ~1.5 mi to the park entrance on the right (N). Trail segments are visible crossing under the western end of the Hell Creek bridge. OR, from I-70, take Exit 199 N (Dorrance). Drive north 3 mi on 200th Road, then east 5 mi on Shoreline Drive to the park entrance on the left (N). Camping is available at Wilson State Park, both tent camping and full hookup. The closest hotel is in Wilson. Other hotels within 50 minutes of Wilson Lake are in Russell, Salina, Ellsworth and Hays. Restrooms and showers are located at the trailhead parking lot. Restrooms will be closed after October 15th. So, 50k'ers beware, it will be primitive bathrooms! The trail start will be at the trailhead for Switchgrass Trail. This is in the Hell Creek Area of Wilson State Park. Many other details can be found on the website, www.wildwithinyou.com Have other questions? Email me at [email protected] This is a fun event! I do not place emphasis on winning First, Second, Third… I want to encourage all people to attend Wild Within You events! Novice and experts alike, come on out and challenge yourself on the trail!
- Address:Switchgrass Trailhead
Wilson State Park, KS, KS 67490


text:
SANTA CRUZ -- Sandra Faber, a professor of astronomy and astrophysics at UC Santa Cruz and the interim director of UC Observatories, has been selected by President Obama to receive the National Medal of Science, the White House announced Friday.
Faber will receive the award from the president, along with a dozen other researchers, early next year. The award, along with the National Medal of Technology and Innovation, are considered the highest honors the U.S. government gives to scientists, engineers and inventors, according to a statement from the university.
"Receiving the National Medal of Science is the thrill of a lifetime, but good science does not happen in isolation," Faber said in the university news release. "Let me take this moment to express my gratitude to the University of California Observatories and UC Santa Cruz for providing both world-class telescopes and superb collaborators, without which the discoveries I've made would never have happened."
An observational astronomer with research interests in cosmology and galaxy formation, Faber has made important contributions to scientific progress in understanding the history and structure of the universe. Faber also has received the Franklin Institute's 2009 Bower Award and Prize for Achievement in Science and two awards in 2012 for lifetime scientific achievement.
Faber currently leads the CANDELS project, the largest project in the history of the Hubble Space Telescope, to extend the view of galaxy formation back nearly to the Big Bang.
"In her years at UC Santa Cruz, Sandy has amassed an amazing record of scientific achievement, innovation, and excellence in teaching," said UCSC Chancellor George Blumenthal, an astronomer and longtime colleague of Faber's. "I am absolutely delighted that she has been selected to receive the National Medal of Science, an honor that Sandy richly deserves."


text:
Gainesville knocked off host Eastside 48-24 before getting past Buchholz 43-33.
Gainesville High School continued its dominance on the wrestling mats Friday by winning its third consecutive city championship.
The Hurricanes showed they were the more experienced team, knocking off host Eastside 48-24 before getting past Buchholz 43-33.
Thomas Herlevich, Marcellus Boyd and Wade Jones combined to earn 36 of Gainesville's 91 total points by winning their respective matches by pins.
Herlevich pinned Eastside's Alex Whaley in his first match and squeezed in his second pin of the night against Buchholz's Peter Emery at the 3:59 mark. The senior won the 145-pound weight class.
"Our goal for the whole team was to come out fast and aggressive and (Thomas) did exactly that," Gainesville High coach Ryland Wagner said. "Thomas is a great story. He has a 4.3 GPA. Started wrestling in the ninth grade and made it to states in just his sophomore year. He wants to go out on the right note."
Boyd got his first pin in the nick of time. He held down Eastside's Shannon Powell with just one second to spare in a match where the referee called for action several times. Boyd's second pin came against Anthony Moore of Buchholz to win the 138-pound weight class.
The 170-pound weight class belonged to Jones by making quick work of both of his opponents. Jones first pinned Eastside's Romell Thomas in just 59 seconds. His lightning-quick work of Jared Rogers lasted just 18 seconds.
Hurricane teammates joining Herlevich, Boyd and Jones as weight class winners included Treavon O'Neil (106 pounds), Tajh Brennan (113 pounds), Matt Tamayo (138 pounds) and Vlad Dubinin (182 pounds).
The match that was the most pivotal in deciding the championship belonged to one of the youngest and smallest Hurricane wrestlers.
Brennan, just a sophomore who has jumped back and forth between varsity and JV this year, was seen as an underdog in his second match of the night against the older Joe Levine of Buchholz. Brennan took advantage of Levine's mental mistakes, wore him down and stole three points. The Gainesville team and coaching staff were ecstatic with the upset.
"He was our team MVP tonight and this is his first year wrestling," Wagner said. "The goal we set for him was not to get pinned. His win gave us so much momentum. It was critical because the score could have only been (a four-point lead) if it went the other way."
"That is all I was thinking the whole time, 'Don't get pinned, don't get pinned,'" Brennan said. "He made a few mental mistakes and I grinded it out."
Buchholz won the second-place match, beating Eastside 45-27.
Four Buchholz wrestlers won their respective weight classes: Lorenzo Smith (126 pounds), Myckel Hutchinson (152 pounds), Vinny Sunter (195 pounds) and Deontiae Neal (heavyweight).
Eastside's winners included Rashad Bennett (120 pounds), Jesse Houston (160 pounds) and Mike Linton (220 pounds).


text:
Dockers sponsor fined $3 million for unlawful imports
- Steve Dank linked to 'rejuvenation' clinic selling peptides online
- JOHN SILVESTER: A-League match probed over big betting plunge
- AFL outlines plan to curb drug use
- Report points the finger at doctors
- Gambling ads to face inquiry
- RICHARD HINDS: Blame will weigh on sports administrators
A FORMER supplier of nutritional supplements to the Fremantle Football Club has been prosecuted and fined $3.1 million for unlawfully importing unregistered substances.
Federal Court records show Export Corporation (Australia) Pty Ltd was last year found guilty by Justice Nye Perram of 35 unlawful importations between 2007 and 2008.
The company is the parent of sports nutrition business Nutrition Systems. Its sole director is Perth fitness identity Danny Pavlovich.
Nutrition Systems was originally contracted to sponsor the Dockers between 2008 and 2011, although a club spokesman has said the deal actually ended in 2009. It is believed the company's supplements were not extensively used during the period.
Fairfax Media is not suggesting any Fremantle players have used illegal substances. Nor is it suggesting Nutrition Systems supplied any banned substances to the club.
However, the case highlights the potential risks professional sporting clubs face in accessing sports supplements through third parties.
The revelation comes in the midst of the Australian Crime Commission's bombshell findings from a 12-month investigation that organised crime syndicates had forged links to elite sporting clubs - even to the extent of providing them with illegal performance-enhancing substances.
Essendon Football Club also confirmed on Thursday that senior coach James Hird had received dietary advice from a convicted drug trafficker alleged to have provided potentially illegal supplements to the club's sports science staff last year.
Hird worked with biochemist Shane Charter in 2003 and 2004 while club captain. There is no suggestion Hird ever took banned substances.
Mr Charter was arrested by Victoria Police drug squad detectives in 2004 after being found in possession of 100,000 pseudoephedrine tablets. He received a reduced prison term after striking a deal with Crown prosecutors to testify against a co-accused later found not guilty.
Fairfax Media has learnt that during his prosecution, investigators compiled a list of about 30 high-profile AFL players who were working closely with Mr Charter. It is believed the names could have been disclosed during the prosecution had he not struck the Crown deal.
Sources say Mr Charter was highly regarded in the fitness scene in the early 2000s. It is understood several Essendon players attended a training camp near Bendigo run by him around 2003-04.
In the Export Corporation case, court papers show 35 separate imports of supplements by Nutrition Systems during 2007 and 2008 involved substances not listed on the Australian Register of Therapeutic Goods. Three of the imports were found to have substances that were not disclosed on the packaging, which the secretary of the Department of Health and Ageing alleged was a serious contravention because of their potentially harmful effects.
Many more imports were found to include substances that required a prescription.
The products included supplements to increase muscle growth, reduce fat and boost sexual performance.
Justice Perram found Export Corporation's unlawful imports were not the result of a systematic plan but more likely ''an error of systems control''.
In its defence, the company said it had misunderstood an import consultant's advice.
The judge found the company had co-operated with the Therapeutic Goods Administration and handed over unlawful products without an order being sought. But he criticised the firm for events in 2006 involving it and the TGA ''which signal a degree of nonchalance on its part towards compliance''.
''Export Corporation now agrees that its response to those matters was inadequate and based upon a mistaken belief that the TGA's concerns could be addressed by taking certain steps which it now accepts were not sufficient,'' the judge found.
The company now employs full-time compliance staff.
Mr Pavlovich could not be reached for comment.
An Export Corporation spokesman said its compliance with regulatory standards had improved markedly.
Get the Morning Edition
Sign up for our daily wrap of the news you need to start your day.


text:
The Expression and Significance of MiRNA
Recruitment status was: Recruiting
|Tracking Information
|First Received Date ICMJE
|December 9, 2008
|Last Updated Date
|March 27, 2014
|Start Date ICMJE
|July 2008
|Estimated Primary Completion Date
|December 2015 (Final data collection date for primary outcome measure)
|Current Primary Outcome Measures ICMJE
|evaluate if miRNa profile and markers of inflammation in patients with PAH. These profiles may enable us differentiate patients that have PAH. This may assist in predicting response to therapy and enable us to optimize their treatment. may also shed s [ Time Frame: end of study ]
|Original Primary Outcome Measures ICMJE
|Same as current
|Change History
|Complete list of historical versions of study NCT00806312 on ClinicalTrials.gov Archive Site
|Current Secondary Outcome Measures ICMJE
|Not Provided
|Original Secondary Outcome Measures ICMJE
|Not Provided
|Current Other Outcome Measures ICMJE
|Not Provided
|Original Other Outcome Measures ICMJE
|Not Provided
|Descriptive Information
|Brief Title ICMJE
|The Expression and Significance of MiRNA
|Official Title ICMJE
|The Expression and Significance of miRNA Profile and Markers of Inflammation in Patients With Pulmonary Arterial Hypertension
|Brief Summary
It is not always known what causes PAH or what the best treatment is. The doctors doing this study would like to understand more about why some people develop PAH and other do not. They also would like to learn more about which treatments might help PAH and which people might respond better to treatments.
Doctors think that testing certain substances found in blood cells might help answer these questions. These substances are normally released by our bodies to protect us from infection and to tell the difference between normal and foreign substances in our body. Finally, a new test will study very small molecules called microRNA that control how our genes are expressed. This study is being done to see if blood samples can be tested to determine who might develop PAH, how well drugs will work to treat PAH and to learn more about the development of PAH.
|Detailed Description
You will be asked to donate blood when you have your right heart catheterization and also at the 3-4 month follow-up visit. The amount of blood collected during your heart catheterization is about 20cc (about 4 teaspoons). This blood is discarded as part of the clinical catheterization procedure, but we are asking that we use it for this research study. Then, at the follow-up right heart catheterization, you will be asked to donate 20 cc (which is about 4 teaspoons) of blood.
If the second right heart is not required for clinical purposes then you will be asked to give a blood sample during your 3-4 month follow up clinic visit.
If you require an additional right heart catheterization, within one year, we will ask that you donate additional samples at the subsequent RHC.
Other data collected as part of your clinical care, such as medical history, chest x-ray (picture of your lungs), echocardiogram (picture of your heart), ventilation perfusion scan (determines how much blood goes to your lungs), chest CT (thin pictures of my lungs as slices), pulmonary function tests (breathing tests), and lab blood tests, will be used as part of this research.
|Study Type ICMJE
|Study Design ICMJE
|Observational Model: Case Control
Time Perspective: Prospective
|Target Follow-Up Duration
|Not Provided
|Retention: Samples With DNA
|Sampling Method
|Non-Probability Sample
|Study Population
|We expect to enroll 200 patients, who have been referred to the Pulmonary Hypertension Clinic at the Ohio State University Medical Center, in this study. Patients who are ≥ 18 years of age, not pregnant, and undergoing right heart catheterization for PAH diagnosis as part of their clinical care will be approached for consent and participation in this study.
|Condition ICMJE
|Pulmonary Arterial Hypertension
|Intervention ICMJE
|Not Provided
|Study Groups/Cohorts
|Publications *
|Not Provided
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
|Recruitment Information
|Recruitment Status ICMJE
|Unknown status
|Estimated Enrollment ICMJE
|Estimated Completion Date
|December 2015
|Estimated Primary Completion Date
|December 2015 (Final data collection date for primary outcome measure)
|Eligibility Criteria ICMJE
Inclusion Criteria:
Exclusion Criteria:
|18 Years and older (Adult, Senior)
|Accepts Healthy Volunteers
|Contacts ICMJE
|Contact information is only displayed when the study is recruiting subjects
|Listed Location Countries ICMJE
|United States
|Removed Location Countries
|Administrative Information
|NCT Number ICMJE
|Other Study ID Numbers ICMJE
|Has Data Monitoring Committee
|U.S. FDA-regulated Product
|Not Provided
|IPD Sharing Statement
|Not Provided
|Responsible Party
|Namita Sood, The Ohio State University
|Study Sponsor ICMJE
|Namita Sood
|Collaborators ICMJE
|Not Provided
|Investigators ICMJE
|PRS Account
|Ohio State University
|Verification Date
|February 2014
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP


text:
To the Valley News:
Retiring Assemblywoman Teresa Sayward has been a great representative for our district over the past decade. So, her endorsement of Dan Stec, along with over 30 local respected officials leads me to believe he is the right guy for the job.
Dan has been serving as the Queensbury Town Supervisor since 2004. He knows what we want at the local level and what we need – lower property taxes and economic growth. As a Town Supervisor Mr. Stec has led the charge in keeping taxes down, he has even managed to return almost $10 million in rebates to his constituents!
Clearly Mr. Stec has the experience to serve in the Assembly and make the real changes we desperately need across New York State. Actions speak louder than words, Dan Stec has the track record of success we deserve representing us in Albany!
Vote Stec on November 6.
Lane Sayward, Willsboro


text:
'"I thought during this season that perhaps I should have done a few more games than I did," said Jeanneret, who worked 39 home games and 18 road games this season. "When you pick the games at the start of the season it all looks great. Then in January I had 17 days off. I spent some of them in Florida, I spent some of them with my wife yelling at me around the house, saying 'Why aren't you working?''"'
You are here: Home / SabresBeat / Jeanneret finds he's not really the retiring type


text:
- Home
- News
- Sports
- Opinion
- Obituaries
- Features
- Special Sections
- Classifieds
- Public Notices
Chandler Beach, the boy whose Suwannee River Fair pig — No. 132 — was auctioned for more than $27,000 to benefit Corbin Wiggins' battle against cancer, is recruiting other children to his ministry of good works.
If you currently subscribe or have subscribed in the past to the Chiefland Citizen, then simply find your account number on your mailing label and enter it below.
Click the question mark below to see where your account ID appears on your mailing label.
If you are new to the award winning Chiefland Citizen and wish to get a subscription or simply gain access to our online content then please enter your ZIP code below and continue to setup your account.
|ZIP Code:


text:
Breast Cancer Collection
General Overview
Breast cancer is a disease in which cancer (malignant) cells are found in the tissues of the breast. More
Find answers in our in-depth report on breast cancer:
Diagnostic and Surgical Procedures
Living With Breast Cancer
Medication for women with advanced breast cancer
What promise does Herceptin hold for one of the most aggressive forms of breast cancer?
Preventing Breast Cancer
Breast Cancer Screening: Research and Guidelines
A breakdown of the mammography and breast exam guidelines from the American Cancer Society, American Congress of Obstetricians and Gynecologists, and the United States Preventive Services Task Force (USPSTF).
Preventing Breast Cancer (Continued)
Women should perform a breast self-exam every month. Learn about the exam and how to do it.
Your health may be "all in the family"
Knowing your family's medical history can save your life...and your children's and grandchildren's.
Special Topics
Fibrocystic breast changes: lumps that are normal
Discusses fibrocystic breast changes, a benign condition that affects over half of all women.
Decision making tool: should I have a mammogram?
Weigh the benefits and risks of a mammogram so that you can make an informed decision about your options.
Related Conditions
Natural and Alternative Treatments (By Condition)
Please note, not all procedures included in this resource library are available at Henry Ford Allegiance Health or performed by Henry Ford Allegiance Health physicians.
All EBSCO Publishing proprietary, consumer health and medical information found on this site is accredited by URAC. URAC's Health Web Site Accreditation Program requires compliance with 53 rigorous standards of quality and accountability, verified by independent audits. To send comments or feedback to our Editorial Team regarding the content please email us at firstname.lastname@example.com.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
Editorial Policy | Privacy Policy | Terms and Conditions | Support
Copyright © 2008 EBSCO Publishing. All rights reserved.


text:
FWIW, I agree with the stats. DJA has shot well since he returned to the rotation. And he is very steady with the ball. He would be a pretty good player if he had any size at all. But he is just too easy to pick or push around.
'); var yuipath = 'clientscript/yui'; var yuicombopath = ''; var remoteyui = false; } else // Load Rest of YUI remotely (where possible) { var yuipath = 'http://yui.yahooapis.com/2.9.0/build'; var yuicombopath = 'http://yui.yahooapis.com/combo'; var remoteyui = true; if (!yuicombopath) { document.write('
FWIW, I agree with the stats. DJA has shot well since he returned to the rotation. And he is very steady with the ball. He would be a pretty good player if he had any size at all. But he is just too easy to pick or push around.
I'd definitely take Bayless over Augustin. I'd also consider 4 vs. 5 instead of Augustin.
We really need to figure that out before the playoffs. Hopefully we're active at the deadline.
Whoa, whoa, whoa. While I agree that Garnett shouldn't have made the All-Star team, he by no means is a "6th man type player." He'd not only finish ahead of DeAndre Jordan, he'd start ahead of him.
Paul/Green/Barnes/Griffin/Garnett starting, Crawford/Jordan/Odom/Billups/Hill off the bench, with Green playing the first 8 minutes of the first and third quarters.
This trade would be an all-in move for the Clippers to try to win the title this year. I could see the Celtics and Clippers doing this deal.
The question is would Garnett sign off on this deal. He's fiercely loyal, and may still be with Minnesota if word hadn't leaked that they were trying to trade him.
There are only about 10 players I wouldn't trade for Eric Bledsoe... that would be a great deal for both clubs. Makes that long-awaited Rondo trade possible too.
He can't run a team yet, though. He's pretty much proven that.
It wasn't about being the team everyone loved, it was about beating the teams everyone else loved.
Division Champions 1955, 1956, 1988, 1989, 1990, 2002, 2003, 2005, 2006, 2007, 2008
Conference Champions 1955, 1956, 1988, 2005
NBA Champions 1989, 1990, 2004
It wasn't about being the team everyone loved, it was about beating the teams everyone else loved.
Division Champions 1955, 1956, 1988, 1989, 1990, 2002, 2003, 2005, 2006, 2007, 2008
Conference Champions 1955, 1956, 1988, 2005
NBA Champions 1989, 1990, 2004
I'm posting this here so please don't s*** on me.
@SamAmicoFSO: Column: With NBA trade deadline approaching, Ferry and Hawks in position of power. http://t.co/jQiqFLqc
Houston is one team thats said to have a keen eye on Indiana forward Danny Granger. The Pacers arent totally against keeping the 29-year old forward, who has missed the all of the season with a knee injury. But following the emergence of All-Star Paul George, they are taking and making exploratory calls.
It's likely that the Pacers are simply gauging what his trade value is in the upcoming offseason. As you have highlighted.....Granger's value is probably a Prospect+Expiring+2nd round pick ( what Rudy got the Grizzlies )
Ash from Army of Darkness: Good...Bad...I'm the guy with the gun.
what the hell would houston even give us?
Chandler Parsons+ Patterson or Dontas or Terrence Jones or Morris for Granger makes sense for us not really for the Rockets. We really aren't great trade fits. However if we could get Parsons I do it he is on a cheap deal for 2 more years would let us pay West and be flexible
Last edited by pacer4ever; 02-04-2013 at 02:32 AM.
I tire of writers making up whatever they feel like saying and acting like it's fact.
I'd assume that Patrick Patterson would be a good place to start....but I think that the Salaries would be too hard to match. It's very hard to get salaries to work when we are talking about Granger's $13+ mil 2012-2013 salary.
That's yet another reason why Granger would not likely be moved.
Ash from Army of Darkness: Good...Bad...I'm the guy with the gun.
We can't trade for Parsons because we can't break him and Jeremy Lin up.
Hah, that's true. But it's confusing because his name is so similar to Sam Amick of SI, who's much more reliable.
Houston as a possible trade partner is feasible I guess because they have a lot of young guys, and if we're trading Granger it would be for financial reasons so guys on cheap rookie deals would be attractive. Parsons would be nice but seems unlikely. I think they'd offer up one (or more) of their young PFs.
Allen can't score either. 1 point for the whole game. Is Toronto's "D" that good or Allen's offense that bad? He's not scored a point in either Pacers game.
Parsons is a nice 2nd rd pick who has panned out from the start. I'm not advocating trading Granger, but if Parsons was part of the trade I'd have to really think about it.
3 Feb 013
Bledsoe 23/7/10- 2 Stl & 1 BS
Pierce 22/5/4
P Gasol 23/10/3- 2 Stl
Gay 29/4/2- 3 Stl & 1 BS
W Bynum 18/1/10- 1/0
Earl Clark 17/10/1- 2/2
Drummond 9/11/1- 2/4
Monroe 20/12/2- 0/2
Aaron Gray 6/12
Barbosa 14/2/1- 1/0
Boston 29 Reb and won the game.
At this point he's a glorified Kyle Korver. His job is to knock down open shots. He can't get to the rim anymore, so anytime theirs any type of length or athleticism on Ray, he's not effective anymore.
Jose Calderon finally got his American work visa. Will be an interesting test case against the Knicks tonight.
Gaaaaah how do you miss him!
Michael Beasley:He was cited for driving with a suspended license, driving with excessive speed, driving with expired registration and failure to display a license plate on the rear of the vehicle.
According to the report, the officer noticed Beasley to have "slow speech and slow responses", but said no when asked if he had had anything to drink or taken any medications or drugs....
Another officer arrived on the scene and helped to administer a DUI investigation, and it was determined that he was not impaired.
plus his loaded gun was legally owned.
The poster "pacertom" since this forum began (and before!). I changed my name here to "Slick Pinkham" in honor of the imaginary player That Bobby "Slick" Leonard picked late in the 1971 ABA draft (true story!).


text:
You are not permitted to download, save or email this image. Visit image gallery to purchase the image.
It probably wasn't the latter because the Black Caps have had too many bad days in recent times, but this was undoubtedly another one. They were dismissed for just 86 - their third-worst total in Twenty20 cricket history - and South Africa romped home in 12.1 overs for the loss of just two wickets in the first of three T20 internationals.
There had been a smidgen of optimism that New Zealand would be able to compete with the hosts in the shortest format of the game, particularly as both sides had a number of new faces, the Black Caps convincingly won a warmup game against South Africa A and anything can happen in Twenty20 cricket.
New Zealand's capitulation, however, was a sadly familiar tale. They were often the architects of their own downfall as they adopted an aggressive approach and it was largely left to the four debutants to try salvage something.
They slumped to 36-6 and only Colin Munro (23) and Doug Bracewell (21) ensured they passed the 80 New Zealand scored against Pakistan in Christchurch in 2010 and 81 against Sri Lanka in Lauderhill the same year.
It wasn't the way Brendon McCullum wanted to start his stint as New Zealand captain since the Ross Taylor saga but he said they were simply too aggressive.
"We obviously wanted to be aggressive today and we wanted to put South Africa under pressure right from the get-go but I think we learned a little bit about earning the right to do that," he said.
"[We also learned] that you have to stick to your fundamentals first and foremost and give yourselves that opportunity and platform to then be aggressive.
"It's something we will definitely take out of this game. We were a little over-keen to put some pressure on South Africa from the outset."
The reverse happened as batsmen came and went in a steady procession. Most hit across the line or chose inopportune moments to try to attack the bowling and they didn't really adapt to what was often a two-paced wicket.
Even as the wickets continued to fall, the Black Caps refused to deviate from their attacking intent and it was only when they were 60-8 did Bracewell and Roni Hira try to accumulate a little more.
It gave the bowlers precious little to work with. Mitchell McClenaghan was dangerous early, snaring the wicket of Richard Levi in the first over, but Henry Davids (20), Faf du Plessis (38 not out) and Quinton de Kock (28 not out) quickly took the game away from New Zealand.
The Black Caps have little time to dwell on the match, with the second Twenty20 international in East London on Monday morning (NZT), and McCullum said they would be better.
"[We want] to ensure we continue with our aggressive intent but make sure we stick to the fundamentals and give ourselves a real opportunity before we try to put the hammer down," he said.
"I know we will be better for the experience and in 48 hours' time we will definitely put in a much better performance. We definitely believe we can win that game."
They will hope both Martin Guptill and Trent Boult overcome the stomach bug that kept them out of this morning's game but otherwise coach Mike Hesson will need to stick with his largely inexperienced side.
It's not the end of the world but the Black Caps have to improve significantly.
- Michael Brown of APNZ


text:
Pre-packaged in quantities of 25 grow bags for easy handling. Durable & excellent quality bags. Holes in the bottom allow proper drainage.
Sold in pack or case quantities only.
— Ships from SS: WA, CA, CO, MI, TN, PA, FL USA. Note: the WA warehouse is moving in Jul & Aug, some orders may be delayed 1-2 days.